Odyssey Therapeutics, Inc.
ODTX · XNASCIK 1882782fmd_1HQRMVPC1R38S1CZE9PEAAPSYQManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2025 to Sep 30, 2026, 6 periods
News summary
An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.
AI-written
0 filings
From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).
Loading